169 related articles for article (PubMed ID: 19075546)
21. [The disappearance of CD20 positive lymphocytes in the pleural effusion after intrapleural application of rituximab].
Kalac M; Kolonić SO; Kardum-Skelin I; Planinc-Peraica A; Siftar Z; Jaksić B
Acta Med Croatica; 2007 Sep; 61(4):425-7. PubMed ID: 18044481
[TBL] [Abstract][Full Text] [Related]
22. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved.
Castillo JJ; Shum H; Lahijani M; Winer ES; Butera JN
Leuk Lymphoma; 2012 Dec; 53(12):2378-82. PubMed ID: 22591071
[TBL] [Abstract][Full Text] [Related]
23. Self-limited effusion large B-cell lymphoma: two cases of effusion lymphoma maintaining remission after drainage alone.
Nakatsuka S; Kimura H; Nagano T; Fujita M; Kanda T; Iwata T; Hashimoto K
Acta Haematol; 2013; 130(3):217-21. PubMed ID: 23816805
[TBL] [Abstract][Full Text] [Related]
24. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia.
Tsagarakis NJ; Argyrou A; Gortzolidis G; Kentrou N; Papadhimitriou SI; Tzanetou K; Kakiopoulos G; Papadimitriou KA; Skoumi D; Paterakis G
Int J Hematol; 2009 Jul; 90(1):94-98. PubMed ID: 19484335
[TBL] [Abstract][Full Text] [Related]
25. Human Herpes-8 virus copy to cell ratio: A diagnostic tool in primary effusion lymphoma.
Carne S; Smit E; Price N; Paul J; Guiver M; Tedder R
J Clin Virol; 2019 Jul; 116():7-10. PubMed ID: 30991238
[TBL] [Abstract][Full Text] [Related]
26. Rituximab is effective for human herpesvirus-8-negative primary effusion lymphoma with CD20 phenotype associated hepatitis C virus-related liver cirrhosis.
Takao T; Kobayashi Y; Kuroda J; Omoto A; Nishimura T; Kamitsuji Y; Fukiya E; Nakamura C; Kimura S; Yoshikawa T
Am J Hematol; 2004 Dec; 77(4):419-20. PubMed ID: 15551361
[No Abstract] [Full Text] [Related]
27. Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
Shah NN; Harrison N; Stonecypher M; Frank D; Amorosa V; Svoboda J
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e157-60. PubMed ID: 25027567
[No Abstract] [Full Text] [Related]
28. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
[TBL] [Abstract][Full Text] [Related]
29. Human herpesvirus 8 in primary effusion lymphoma in an HIV-seronegative male. A case report.
Munichor M; Cohen H; Sarid R; Manov I; Iancu TC
Acta Cytol; 2004; 48(3):425-30. PubMed ID: 15192964
[TBL] [Abstract][Full Text] [Related]
30. Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.
Stingaciu S; Ticchioni M; Sudaka I; Haudebourg J; Mounier N
Clin Adv Hematol Oncol; 2010 May; 8(5):367-74. PubMed ID: 20551896
[No Abstract] [Full Text] [Related]
31. Primary effusion lymphoma (PEL) revisited: a hematologist's perspective.
Desai S; Freeman NJ
Clin Adv Hematol Oncol; 2004 Jan; 2(1):60-1. PubMed ID: 16163162
[No Abstract] [Full Text] [Related]
32. HHV-8-associated lymphoma: state-of-the-art review.
Carbone A; Gloghini A
Acta Haematol; 2007; 117(3):129-31. PubMed ID: 17135725
[TBL] [Abstract][Full Text] [Related]
33. Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells.
Boulanger E; Duprez R; Delabesse E; Gabarre J; Macintyre E; Gessain A
Int J Cancer; 2005 Jul; 115(4):511-8. PubMed ID: 15700304
[TBL] [Abstract][Full Text] [Related]
34. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma.
Crane GM; Xian RR; Burns KH; Borowitz MJ; Duffield AS; Taube JM
J Cutan Pathol; 2014 Dec; 41(12):928-35. PubMed ID: 25355615
[TBL] [Abstract][Full Text] [Related]
35. Rare primary effusion lymphoma associated with HHV-8 in Japan.
Ikebe T; Amemiya Y; Saburi M; Ando T; Kohno K; Ogata M; Hiramatsu K; Kadota J
Intern Med; 2010; 49(13):1303-6. PubMed ID: 20606364
[TBL] [Abstract][Full Text] [Related]
36. A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
Siddiqi T; Joyce RM
Clin Lymphoma Myeloma; 2008 Oct; 8(5):300-4. PubMed ID: 18854285
[TBL] [Abstract][Full Text] [Related]
37. KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?
Lambe JS; Oble DA; Nandula SV; Sevilla DW; Colovai AI; Mansukhani M; Chari A; Murty VV; Alobeid B; Bhagat G
Hematol Oncol; 2009 Dec; 27(4):203-10. PubMed ID: 19337983
[TBL] [Abstract][Full Text] [Related]
38. Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease.
Shrestha P; Astter Y; Davis DA; Zhou T; Yuan CM; Ramaswami R; Wang HW; Lurain K; Yarchoan R
Oncoimmunology; 2023; 12(1):2163784. PubMed ID: 36632565
[TBL] [Abstract][Full Text] [Related]
39. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis.
Paner GP; Jensen J; Foreman KE; Reyes CV
Leuk Lymphoma; 2003 Oct; 44(10):1811-4. PubMed ID: 14692539
[TBL] [Abstract][Full Text] [Related]
40. [Human herpesvirus 8-negative primary effusion lymphoma-like lymphoma with t(8;14)(q24;q32)].
Ogasawara Y; Machishima T; Shimada T; Takahashi H; Fukunaga M; Mizoroki F; Dobashi N; Usui N; Aiba K
Rinsho Ketsueki; 2015 Aug; 56(8):1082-8. PubMed ID: 26345571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
